Company Profile
Acesobio, located in Middletown, NY, offers extensive range peptide, small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, HDAC, MAPK etc. to bench scientists across the globe.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
3-MA |
3H-Purin-6-amine,3-methyl-;Adenine,3-methyl-;3-Methyl-3H-purin-6-amine;3-Methyladenine;N3-Methyladenine;6-Amino-3-methylpurine;3-Methyl-6-aminopurine;NSC 66389;3-Methyl-3H-purin-6-ylamine;3-Methylpurin-6-amine |
5142-23-4 | Inquiry | |
AG-1478 |
4-Quinazolinamine,N-(3-chlorophenyl)-6,7-dimethoxy-;N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine;AG 1478;Tyrphostin AG 1478;NSC 693255;(3-Chlorophenyl)(6,7-dimethoxyquinazolin-4-yl)amine;BRD-K68336408;175178-82-2 |
153436-53-4 | Inquiry | |
AG1024 |
AG-1024 (Tyrphostin);2-(3-broMo-5-tert-butyl-4-hydroxybenzylidene)Malononitrile;2-[[3-Bromo-5-(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]propanedinitrile;AGS 200;Tyrphostin;2-[[3-Bromo-5-(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]propanedinitrile AGS 200;HY-10253 |
65678-07-1 | Inquiry | |
AMG-073 |
1-Naphthalenemethanamine,α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-,(αR)-;(αR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine;Cinacalcet;AMG 073;N-[(1R)-1-(1-Naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine;Parareg |
226256-56-0 | Inquiry | |
Apoptosis Activator 2 |
APOPTOSIS ACTIVATOR 2;APOPTOSIS ACTIVATOR II;1-[(3,4-DICHLOROPHENYL)METHYL]-1H-INDOLE-2,3-DIONE;1-(3,4-DICHLOROBENZYL)-1H-INDOLE-2,3-DIONE;1H-Indole-2,3-dione, 1-[(3,4-dichlorophenyl)methyl]-;Apoptosis Activator 2, >=98% |
79183-19-0 | Inquiry | |
ARN-509 |
Benzamide,4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl-;4-[7-[6-Cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide;4-[7-[6-Cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide;ARN 509;A 52;Apalutamide;AR 509;Erleada;1361232-32-7 |
956104-40-8 | Inquiry | |
AST-1306 |
AST-1306;ALS 1306;N-[4-[[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]amino]quinazolin-6-yl]acrylamide;N-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-propenamide |
897383-62-9 | Inquiry | |
AT-406 |
AT-406(AT406);(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(MethylaMino)propanaMido)-3-(3-Methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxaMide;SM 406;(5S,8S,10aR)-N-(Diphenylmethyl)decahydro-5-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-3-(3-methyl-1-oxobutyl)-6-oxopyrrolo[1,2-a][1,5]diazocine-8-carboxamide;AT-406 (SM-406);AT406 (SM-406, ARRY-334543);(5S,8S,10aR)-N-(Diphenylmethyl)decahydro-5-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-3-(3-methyl-1-oxobutyl)-6-oxopyrrolo[1,2-a][1,5]diazocine-8-carboxamideAT406 (SM-406, ARRY-334543);(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahyd |
1071992-99-8 | Inquiry | |
AT9283 |
1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea AT9283;AT9283, >=98%;N-cyclopropyl-N'-[3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]Urea;Urea, N-cyclopropyl-N'-[3-[6-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-;1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea |
896466-04-9 | Inquiry | |
AZD 6244 |
1H-Benzimidazole-6-carboxamide,5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-;5-[(4-Bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide;ARRY 142886;AZD 6244;Selumetinib;NSC 741O78;G 00039805;6-(4-Bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide;Koselugo;AZD6244;AZD-6244;865610-79-3 |
606143-52-6 | Inquiry | |
AZD 7762 |
2-Thiophenecarboxamide,3-[(aminocarbonyl)amino]-5-(3-fluorophenyl)-N-(3S)-3-piperidinyl-;3-[(Aminocarbonyl)amino]-5-(3-fluorophenyl)-N-(3S)-3-piperidinyl-2-thiophenecarboxamide;5-(3-Fluorophenyl)-3-ureidothiophene-2-carboxylic acid N-[(S)-piperidin-3-yl]amide;AZD 7762;1019773-80-8 |
860352-01-8 | Inquiry | |
Bardoxolone |
2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid;Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-;Bardoxolone;CDDO;RTA 401;2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid;Bardoxolone (CDDO);(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-1,3,4,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-hexadecahydropicene-4a(2H)-carboxylic acid |
218600-44-3 | Inquiry | |
Baricitinib |
3-Azetidineacetonitrile,1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-;1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile;LY 3009104;Baricitinib;INCB 028050;INCB 28050;Olumiant;2-(3-(4-(3H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile;1231199-29-3;1374987-77-5 |
1187594-09-7 | Inquiry | |
Boceprevir |
3-Azabicyclo[3.1.0]hexane-2-carboxamide,N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-,(1R,2S,5S)-;(1R,2S,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;Sch 503034;Boceprevir;EBP 520;Victrelis;Boceprevirertet |
394730-60-0 | Inquiry | |
CAL101 |
4(3H)-Quinazolinone,5-fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-;4(3H)-Quinazolinone,5-fluoro-3-phenyl-2-[(1S)-1-(1H-purin-6-ylamino)propyl]-;5-Fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-4(3H)-quinazolinone;CAL 101;GS 1101;Idelalisib;Zydelig;N6-[(S)-1-(5-Fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl]adenine;Delalisib;(S)-2-(1-((9H-Purin-6-yl)amino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one |
870281-82-6 | Inquiry | |
Cathepsin Inhibitor 1 |
N-[(1S)-1-[(3-Chlorophenyl)methyl]-2-[(cyanomethyl)amino]-2-oxoethyl]-3-(1,1-dimethylethyl)-1-methyl-1H-pyrazole-5-carboxamide;Cathepsin Inhibitor 1;1H-Pyrazole-5-carboxamide, N-[(1S)-1-[(3-chlorophenyl)methyl]-2-[(cyanomethyl)amino]-2-oxoethyl]-3-(1,1-dimethylethyl)-1-methyl- |
225120-65-0 | Inquiry | |
ciproxifan maleate |
Ciproxifan Moleate;FUB 359 Maleate;FUB359 Maleate;FUB-359 Maleate;Cyclopropyl (4-[3-(1H-imidazol-4-yl)propyloxy]phenyl) ketone maleate salt;Ciproxifan maleate, >=98%;(4-(3-(1H-Imidazol-5-yl)propoxy)phenyl)(cyclopropyl)methanone maleate;CIPROXIFAN |
184025-19-2 | Inquiry | |
CPI-613 |
Octanoic acid,6,8-bis[(phenylmethyl)thio]-;Octanoic acid,6,8-bis(benzylthio)-;6,8-Bis[(phenylmethyl)thio]octanoic acid;CPI 613;Devimistat;6,8-Bis-benzylthio-octanoic acid;SML 0404 |
95809-78-2 | Inquiry | |
Everolimus |
Rapamycin,42-O-(2-hydroxyethyl)-;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rapamycin deriv.;42-O-(2-Hydroxyethyl)rapamycin;40-O-(2-Hydroxyethyl)rapamycin;SDZ-RAD;RAD 001;Everolimus;RAD;Certican;XIENCE V;Afinitor;Zortress;Xience;Afinitor Disperz;Votubia;1245613-55-1;2413306-61-1 |
159351-69-6 | Inquiry | |
EX-527 |
SelisistatS-enantiomer;EX527;(1S)-6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide;EX-527(S),(1S)-6-ChlorChemicalbooko-2,3,4,9-tetrahydro-1H-carbazole-1-carboxaMide;EX-527(S-enantioMer);SelisistatS-enantiomer(EX-527S-enantiomer) |
848193-68-0 | Inquiry |
CONTACT INFORMATION
Sign In for Details